TD Cowen analysts say the rate updates of the Centers for Medicare and Medicaid Services’ proposed rule for hospital outpatient and ambulatory surgery center procedures will be overshadowed by a proposal to eliminate the inpatient only list, which is positive for Surgery Partners (SGRY) and United Surgical Partners (USPI), and the 340B remedy reduction higher from 0.5% to 2.0% per year, which is likely negative for HCA Healthcare (HCA), Tenet Healthcare (THC) and Universal Health (UHS). However, the firm expects this to be lobbied by the American Hospital Association and awaits additional commentary from the industry. The rule projects an overall 2.4% rate update for outpatient hospital and ambulatory surgery center procedures, the analysts tell investors in a research note. Shares of HCA are down 3% to $359.09 in morning trading while Surgery Partners is up 2% to $22.38.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA: